NO922744L - Peptidblanding og fremgangsmaate ved paavisning av antistoffer htlv-ii - Google Patents

Peptidblanding og fremgangsmaate ved paavisning av antistoffer htlv-ii

Info

Publication number
NO922744L
NO922744L NO922744A NO922744A NO922744L NO 922744 L NO922744 L NO 922744L NO 922744 A NO922744 A NO 922744A NO 922744 A NO922744 A NO 922744A NO 922744 L NO922744 L NO 922744L
Authority
NO
Norway
Prior art keywords
detection
assay
aids
peptid
htlv
Prior art date
Application number
NO922744A
Other languages
English (en)
Other versions
NO922744D0 (no
Inventor
Chang Yi Wang
James Jian Guang Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21757877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO922744(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO922744L publication Critical patent/NO922744L/no
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of NO922744D0 publication Critical patent/NO922744D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Den foreliggende oppfinnelse vedrører en fremgangsmåte for påvisning og'diagnostikk av AIDS, (ervervet immunsvikt-syndrom) ARC (AIDS-relatert kompleks) og pre-AIDS-tilstander i kropps- fluider ved anvendelse av en kjemisk syntetisert peptidsammen- setning. Påvisningsmetoden inkluderer en enzymbundet immuno- sorbent assay (ELISA), en immunoradiometrisk assay (IRMA) og andre former for immunoassayprosedyrer, slik som enzymimmuno- blotting assay på nitrocellulosepapir og hemagglutinasjonsassay ved å anvende peptidsammensetningen som antigen. Den foretrukne påvisningsroetode er EuISA.
NO922744A 1987-02-10 1992-07-10 Peptidblanding og fremgangsmaate ved paavisning av antistoffer htlv-iii NO922744D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/013,014 US4879212A (en) 1986-04-02 1987-02-10 Peptide composition and method for the detection of antibodies to HTLV-III

Publications (2)

Publication Number Publication Date
NO922744L true NO922744L (no) 1988-08-11
NO922744D0 NO922744D0 (no) 1992-07-10

Family

ID=21757877

Family Applications (2)

Application Number Title Priority Date Filing Date
NO872473A NO175482C (no) 1987-02-10 1987-06-15 Peptidblanding for in vitro påvisning av antistoffer mot HTLV-III, anvendelse derav og prövesett for denne
NO922744A NO922744D0 (no) 1987-02-10 1992-07-10 Peptidblanding og fremgangsmaate ved paavisning av antistoffer htlv-iii

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO872473A NO175482C (no) 1987-02-10 1987-06-15 Peptidblanding for in vitro påvisning av antistoffer mot HTLV-III, anvendelse derav og prövesett for denne

Country Status (12)

Country Link
US (1) US4879212A (no)
EP (1) EP0278148B1 (no)
JP (1) JP2675009B2 (no)
AT (1) ATE114672T1 (no)
CA (1) CA1280363C (no)
DE (1) DE3750812T2 (no)
DK (1) DK296087A (no)
ES (1) ES2064316T3 (no)
HK (1) HK155795A (no)
IL (1) IL82847A0 (no)
NO (2) NO175482C (no)
ZA (1) ZA874759B (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006414A1 (en) 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US6130314A (en) * 1986-03-26 2000-10-10 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US5681696A (en) * 1987-01-09 1997-10-28 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV
US5476765A (en) * 1987-01-09 1995-12-19 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV and as vaccines
AU614521B2 (en) * 1987-04-16 1991-09-05 Johnson & Johnson Stlv-iii-related polypeptides, diagnostic systems and assay methods
JPH0215098A (ja) * 1987-05-18 1990-01-18 Virovahl Sa Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
US20030022826A1 (en) * 1987-09-08 2003-01-30 Duke University Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
JPH01163198A (ja) * 1987-12-28 1989-06-27 Birobaaru Sa Ｈｉｖ−２感染検出用合成ペプチド抗原、その組成物およびその使用方法
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6218102B1 (en) * 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5516632A (en) * 1988-02-08 1996-05-14 Duke University Synthetic peptides
CA1335880C (en) * 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
CA2003300A1 (en) * 1988-11-21 1990-05-21 Franklin Volvovitz Skin test and test kit for aids
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
US5882853A (en) * 1989-09-01 1999-03-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating HTLV-I-specific T cell responses
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
US5654401A (en) * 1990-11-28 1997-08-05 The Johns Hopkins University Borna disease virus-specific protein and kits
DK0489968T3 (da) * 1990-12-14 1997-03-24 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
US7119182B1 (en) 1991-02-19 2006-10-10 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
AU2879292A (en) * 1991-10-08 1993-05-03 Duke University Peptides corresponding to antigenic determinants of htlv
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6962982B2 (en) * 2001-06-22 2005-11-08 Roche Diagnostics Corporation Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
US7094884B2 (en) * 2001-06-22 2006-08-22 Roche Diagnostics Corporation Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
CA2449747C (en) 2001-06-22 2010-04-13 F. Hoffmann-La Roche Ag Use of fkbp chaperones as expression tool
US7094757B2 (en) * 2001-06-22 2006-08-22 Roche Diagnostics Corporation Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them
AU2005267607B8 (en) * 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
ES2327340T3 (es) * 2003-09-11 2009-10-28 Idexx Laboratories, Inc. Procedimiento y dispositivo para detectar el virus de la inmunodeficiencia felina.
US7285272B2 (en) * 2003-12-18 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005215629B2 (en) * 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267608B2 (en) * 2004-06-30 2009-01-15 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (FIV) comprising the use of peptides derived from the V3 region of the FIV env protein
FR2874017B1 (fr) * 2004-08-06 2006-11-24 Bio Rad Pasteur Sa Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2688724C (en) * 2007-05-21 2016-03-29 The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services Novel simian t-cell lymphotropic virus
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
CN103134709A (zh) * 2011-11-30 2013-06-05 内蒙古蒙牛乳业（集团）股份有限公司 检测原料奶中孕酮含量的前处理方法及检测方法
CN103134717B (zh) * 2011-11-30 2015-04-08 内蒙古蒙牛乳业（集团）股份有限公司 检测乳酸菌饮料中雌二醇含量的前处理方法及检测方法
CN103134715A (zh) * 2011-11-30 2013-06-05 内蒙古蒙牛乳业（集团）股份有限公司 检测乳酸菌饮料中催乳素含量的前处理方法及检测方法
CN103134716A (zh) * 2011-11-30 2013-06-05 内蒙古蒙牛乳业（集团）股份有限公司 检测乳酸菌饮料中孕酮含量的前处理方法及检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
JPS60501122A (ja) * 1983-04-20 1985-07-18 アプライド　モ−シヨン　プロダクツ、インコ−ポレ−テツド 改良された磁気シ−ル組立体
US5063150A (en) * 1984-09-19 1991-11-05 The Regents Of The University Of California Retroviral polypeptides associated with human cellular transformation
DE3588254T2 (de) * 1984-10-18 2008-06-26 Institut Pasteur GAG-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3688051T2 (de) * 1985-12-17 1993-06-24 Akzo Nv Immunochemisches reagenz.
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharmaceutical Corp., Raritan Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
EP0247557B1 (en) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV) Envelope peptides
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant

Also Published As

Publication number Publication date
JPS63196856A (ja) 1988-08-15
DE3750812D1 (de) 1995-01-12
ZA874759B (en) 1988-01-05
DE3750812T2 (de) 1995-06-22
CA1280363C (en) 1991-02-19
EP0278148B1 (en) 1994-11-30
NO922744D0 (no) 1992-07-10
NO872473D0 (no) 1987-06-15
DK296087D0 (da) 1987-06-10
NO175482B (no) 1994-07-11
ATE114672T1 (de) 1994-12-15
DK296087A (da) 1988-08-11
JP2675009B2 (ja) 1997-11-12
ES2064316T3 (es) 1995-02-01
EP0278148A2 (en) 1988-08-17
EP0278148A3 (en) 1990-06-06
HK155795A (en) 1995-10-06
NO175482C (no) 1994-10-19
NO872473L (no) 1988-08-11
IL82847A0 (en) 1987-12-20
US4879212A (en) 1989-11-07

Similar Documents

Publication Publication Date Title
NO922744L (no) Peptidblanding og fremgangsmaate ved paavisning av antistoffer htlv-ii
ES8801839A1 (es) Procedimiento para detectar anticuerpos a htlv-iii y diagnosticar aids, arc o estados pre-aids
JP3231666B2 (ja) 新ペプチド、人工抗原およびイムノアッセイキット
KR860700046A (ko) HTLV-Ⅲ 단백질의 분리, AIDS와 pre-AIDS 증상환자 혈청중의 HTLV-Ⅲ에 대한 항체의 혈청학적 검출 및 HTLV-Ⅲ과 이것의 단백질을 사용하는 면역 분석에 의한 HTLV-Ⅲ감염의 검사
CA2016313A1 (en) Process for preparing an improved western blot immunoassay
EP0151320A3 (en) Pure alkaline phosphatase, its preparation and use
AU2314088A (en) Method for rapid and sensitive detection of igm retroviral antibodies
FR2637600B1 (fr) Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
Beyzavi et al. Comparison of horseradish peroxidase and alkaline phosphatase-labelled antibodies in enzyme immunoassays
Ivanov et al. Effective method for synthetic peptide immobilization that increases the sensitivity and specificity of ELISA procedures
CA2025019A1 (en) Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1
KR870011154A (ko) Htlv-iii바이러스 관련 펩티드, 이에 대한 항체, 백신, aids 바이러스에 대한 수동 및 자동 면역 및 aids 바이러스의 혈청학적 진단을 위한 진단시험
CA2034611A1 (en) Synthetic peptide compositions with immunoreactivities to antibodies to htlv
Poli et al. Microplate enzyme-linked immunosorbent assay for bovine leukemia virus antibody
HK1003795A1 (en) Monoclonal antibodies recognizing alpha-hanp and corresponding hybridomas their preparation and use
ES2101763T3 (es) Acoplamiento de antigenos y anticuerpos a eritrocitos no fijados.
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
JPH04503110A (ja) ＡＩＤＳ進行監視用　ＨＩＶ　ｐ１７　アッセイ
Ujhelyi et al. Effect of pepsin treatment on the HIV envelope and core antigens
NZ297230A (en) Thiepane compounds for detecting HIV protease
JPH02500590A (ja) ペプチド